JP2008540557A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540557A5
JP2008540557A5 JP2008511333A JP2008511333A JP2008540557A5 JP 2008540557 A5 JP2008540557 A5 JP 2008540557A5 JP 2008511333 A JP2008511333 A JP 2008511333A JP 2008511333 A JP2008511333 A JP 2008511333A JP 2008540557 A5 JP2008540557 A5 JP 2008540557A5
Authority
JP
Japan
Prior art keywords
group
ether group
ether
compound represented
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008511333A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540557A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/018153 external-priority patent/WO2006122216A2/en
Publication of JP2008540557A publication Critical patent/JP2008540557A/ja
Publication of JP2008540557A5 publication Critical patent/JP2008540557A5/ja
Pending legal-status Critical Current

Links

JP2008511333A 2005-05-11 2006-05-11 フェノール型4−ビフェニリルアゼチジン−2−オンの製造方法 Pending JP2008540557A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67978505P 2005-05-11 2005-05-11
PCT/US2006/018153 WO2006122216A2 (en) 2005-05-11 2006-05-11 Processes for production of phenolic 4-biphenylylazetidin-2-ones

Publications (2)

Publication Number Publication Date
JP2008540557A JP2008540557A (ja) 2008-11-20
JP2008540557A5 true JP2008540557A5 (enExample) 2009-08-13

Family

ID=37397290

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511333A Pending JP2008540557A (ja) 2005-05-11 2006-05-11 フェノール型4−ビフェニリルアゼチジン−2−オンの製造方法

Country Status (15)

Country Link
US (1) US20080200669A1 (enExample)
EP (1) EP1885703A4 (enExample)
JP (1) JP2008540557A (enExample)
KR (1) KR20080017345A (enExample)
CN (1) CN101218213A (enExample)
AU (1) AU2006244043A1 (enExample)
BR (1) BRPI0608970A2 (enExample)
CA (1) CA2608075A1 (enExample)
EA (1) EA200702464A1 (enExample)
IL (1) IL187287A0 (enExample)
MA (1) MA29539B1 (enExample)
MX (1) MX2007014172A (enExample)
NO (1) NO20076371L (enExample)
WO (1) WO2006122216A2 (enExample)
ZA (1) ZA200710721B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
KR20070050861A (ko) * 2003-11-10 2007-05-16 마이크로비아 인코포레이티드 4-비아릴일-1-페닐아제티딘-2-온
DE602004029715D1 (de) 2003-12-23 2010-12-02 Astrazeneca Ab Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
TW200726746A (en) * 2005-05-06 2007-07-16 Microbia Inc Processes for production of 4-biphenylylazetidin-2-ones
EA200702450A1 (ru) * 2005-05-09 2008-04-28 Майкробиа, Инк. Металлоорганические бензолфосфонатные связующие вещества
EP1896135A2 (en) * 2005-05-25 2008-03-12 Microbia, Inc. Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
AR057072A1 (es) 2005-06-22 2007-11-14 Astrazeneca Ab Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
BRPI0715160A2 (pt) 2006-08-08 2013-06-11 Sanofi Aventis imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007054497B3 (de) 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
US20120028340A1 (en) * 2009-04-02 2012-02-02 Piyush Suresh Lathi Kinetic resolution of (4s) -- 4- phenyl -- 3- [(5rs)-5-(4-flurophenyl)-5- hydroxypentanoyl] --1,3-oxazolidin-2-one to the (5s) isomer via lipase catalyzed enantioselective esterification of the (5r) isomer
ES2443016T3 (es) 2009-08-26 2014-02-17 Sanofi Nuevos hidratos cristalinos de fluoroglicósidos heteroaromáticos, productos farmacéuticos que comprenden estos compuestos, y su empleo
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
CN102285932B (zh) * 2011-09-01 2013-06-12 浙江大学 一种依替米贝中间体的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69222532T2 (de) * 1991-07-23 1998-02-26 Schering Corp Substituierte beta-lactam-verbindungen als hypocholesterolemische mittel und verfahren zu deren herstellung
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US6207822B1 (en) * 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
AU2030100A (en) * 1998-12-07 2000-06-26 Schering Corporation Process for the synthesis of azetidinones
CA2431983C (en) * 2000-12-21 2010-06-08 Aventis Pharma Deutschland Gmbh Novel 1,2-diphenylazetidinones, processes for their preparation, medicaments comprising these compounds and their use for treating impaired lipid metabolism
IL156552A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
HU230229B1 (hu) * 2001-03-28 2015-10-28 Merck Sharp & Dohme Corp Azetidinon-intermedier vegyületek enantioszelektiv szintézise
EP1626954A2 (en) * 2003-05-05 2006-02-22 Ranbaxy Laboratories, Ltd. Process for the preparation of trans-isomers of diphenylazetidinone derivatives
KR20070050861A (ko) * 2003-11-10 2007-05-16 마이크로비아 인코포레이티드 4-비아릴일-1-페닐아제티딘-2-온
JP2008539255A (ja) * 2005-04-26 2008-11-13 マイクロビア インコーポレーテッド 高コレステロール血症のための4−ビアリーリル−1−フェニルアゼチジン−2−オングルクロニド誘導体
WO2006121861A2 (en) * 2005-05-05 2006-11-16 Microbia, Inc. Biphenylazetidinone cholesterol absorption inhibitors
TW200726746A (en) * 2005-05-06 2007-07-16 Microbia Inc Processes for production of 4-biphenylylazetidin-2-ones

Similar Documents

Publication Publication Date Title
JP2008540557A5 (enExample)
JP2008545700A5 (enExample)
JP2003520235A5 (enExample)
JP2010510976A5 (enExample)
JP2009534468A5 (enExample)
JP2007511546A5 (enExample)
CA2485926A1 (en) (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker
JP2005505565A5 (enExample)
JP2009538336A5 (enExample)
JP2007524706A5 (enExample)
JP2008524374A5 (ja) シロキサン樹脂、シロキサン樹脂の調製方法および抗反射コーティング組成物
JPWO2021030554A5 (enExample)
RU2004126442A (ru) Способ получения ингибиторов hmg-coa редуктазы
JP2008542205A5 (enExample)
JP5115477B2 (ja) 水酸基を有する3−エチルオキセタン化合物及びその製法
US20150057462A1 (en) Methods of preparing low molecular weight carbosilanes and precursors thereof
JP2008526897A5 (enExample)
JP2010504285A5 (enExample)
JP2006514956A5 (enExample)
JP2004018831A5 (enExample)
JP2008503582A5 (enExample)
JP2004010877A5 (enExample)
JP2011513358A5 (enExample)
JP2006512470A5 (enExample)
JP5257353B2 (ja) 置換ヒドロキシメチルフェノールの新規な合成